(4-{[4-(4-Methoxy-phenyl)-thiazol-2-yl]-hydrazonomethyl}-phenyl)-dimethyl-amine | 78559-95-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (4-{[4-(4-Methoxy-phenyl)-thiazol-2-yl]-hydrazonomethyl}-phenyl)-dimethyl-amine
• 英文别名: N-[[4-(dimethylamino)phenyl]methylideneamino]-4-(4-methoxyphenyl)-1,3-thiazol-2-amine
• CAS: 78559-95-2
• 化学式: C₁₉H₂₀N₄OS
• 分子量: 352.46
• InChiKey: FDVKPSBQABTVHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  78
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  对二甲氨基苯甲醛 在 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 1.5h， 生成 (4-{[4-(4-Methoxy-phenyl)-thiazol-2-yl]-hydrazonomethyl}-phenyl)-dimethyl-amine
  参考文献：
  名称：

  噻唑腙衍生物的抗氧化和抗酪氨酸酶活性的合成、评价及其在鲜切马铃薯防褐变中的应用

  摘要：

  酪氨酸酶是黑色素生物合成中的关键酶，黑色素是导致食物褐变和许多皮肤病的原因。为了开发具有双重抗氧化和抗酪氨酸酶能力的新型抗褐变剂，合成了一系列30种噻唑腙衍生物。在制备的分子中，发现6和30是最有效的酪氨酸酶抑制剂，其 IC 50值与曲酸相当。有趣的是，6在制备的分子中也具有最高的自由基清除活性。抑制动力学研究表明6是一种非竞争性抑制剂，而30竞争性抑制酪氨酸酶。鲜切马铃薯片的抗褐变试验表明，6和30是有效的抗褐变剂，其能力与曲酸一样高。自由基清除和酪氨酸酶抑制的机制已在计算机中使用计算动力学、分子对接和分子动力学模拟进行了全面研究。

  DOI：

  10.1016/j.foodchem.2023.135745

文献信息

• Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro
  作者：Nívea Pereira de Sá、Cleudiomar Inácio Lino、Nayara Cristina Fonseca、Beatriz Martins Borelli、Jonas Pereira Ramos、Elaine Maria Souza-Fagundes、Carlos Augusto Rosa、Daniel Assis Santos、Renata Barbosa de Oliveira、Susana Johann

  DOI：10.1016/j.ejmech.2015.07.032

  日期：2015.9

  Human cryptococcosis can occur as a primary or opportunistic infection and develop as an acute, subacute, or chronic, systemic infection involving different host organs. We evaluated the antifungal activity of thirteen compounds against Cryptococcus gattii and Cryptococcus neoformans in vitro, by assessing the toxicity of the compounds showing the greatest antifungal activity in VERO cells and murine macrophages. From these results, four compounds were considered promising for further studies because they displayed low cytotoxicity and significant antifungal activity. The heterocyclic compounds 1b, 1c, 1d, and 1m have antifungal activity levels between that of amphotericin B and fluconazole in vitro. The death curve of Cryptococcus spp. treated with these four compounds was similar to the curve obtained for amphotericin B, in that we observed a significant reduction in cell viability within the first 24 h of treatment. Additionally, we found that there was no effect when these compounds were combined with amphotericin and fluconazole, except for 1c, which antagonized the effect of amphotericin B against C. gattii, also reflected in the reduction of the post-antifungal effect (PAFE); however, this interaction did not alter the ergosterol content. The results shown in this paper reveal the discovery of novel thiazole compounds, which are easy to synthesize, and with potentially exhibit antifungal activity, and display low cytotoxicity in normal mammalian cells. These compounds can be used as prototypes for the design of new antifungal drugs against C gattii and C neoformans. (C) 2015 Elsevier Masson SAS. All rights reserved.